CREBBP c.193_194delinsGT ;(p.S65V)

Variant ID: 16-3900902-GA-AC

NM_004380.2(CREBBP):c.193_194delinsGT;(p.S65V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib.

Oncotargets And Therapy
Cheng, Qiansong Q; Wang, Jing J; Lv, Chenglan C; Xu, Jingyan J
Publication Date: 2021

Variant appearance in text: CREBBP: Ser65Val
PubMed Link: 34079282
Variant Present in the following documents:
  • Main text
View BVdb publication page